Medtech Atmo preps to surf GLP-1 wave
MELBOURNE: Melbourne’s Atmo Biosciences has slashed its valuation from $70 million to $25 million, despite
MELBOURNE: Melbourne’s Atmo Biosciences has slashed its valuation from $70 million to $25 million, despite
FEATURED
City co-housing plans face opposition despite obvious benefits
Assisted living most popular for development but construction remains low
New all-electric development helps elderly age safely and independently
Plan for new multigenerational ‘ecotech’ town on edge of city
Villagers say 550-home scheme with care component risks urban sprawl
Music therapy ignites compensatory brain wiring in dementia
INNOVATION
